Ascot, UK, Dr. Kinney will describe for the first time a new family of molecules with improvements over Cannabidiol (“CBD”), a non-psychoactive neuroprotective agent from C. sativa. IteraMed Consulting has functioned as Kannalife Sciences’ medicinal and...